Novartis Product Recall
Nov. 28, 2024
Novartis Recalls 100 mg Sandimmune and Neoral Prescription Drug Blister Packages Due to Failure to Meet Child-Resistant Packaging Requirement; Risk of Poisoning | CPSC.gov Novartis pulls 2 batches of Sandimmune after spotting crystal formations—again | Fierce Pharma Broken products prompt voluntary Novartis recall | Healthcare Packaging Novartis Product Recall